Short answer · Medically reviewed summary · Last updated: 2026-05-08
Bilateral Renal Agenesis (BRA), also known as Potter sequence, is a rare and severe congenital condition with an estimated incidence of approximately 1 in 4,000 to 1 in 10,000 births. Because the condition is typically incompatible with life due to severe pulmonary hypoplasia, it is almost exclusively identified in the prenatal or neonatal period, making prevalence in the adult population effectively zero. How frequent is Bilateral Renal Agenesis? Bilateral Renal Agenesis is considered a rare condition.
Bilateral Renal Agenesis (BRA), also known as Potter sequence, is a rare and severe congenital condition with an estimated incidence of approximately 1 in 4,000 to 1 in 10,000 births. Because the condition is typically incompatible with life due to severe pulmonary hypoplasia, it is almost exclusively identified in the prenatal or neonatal period, making prevalence in the adult population effectively zero.
Bilateral Renal Agenesis is considered a rare condition. While incidence rates vary by study, the NIH Genetic and Rare Diseases Information Center (GARD) suggests a frequency of roughly 1 in 4,000 live births. It is important to note that these figures may underrepresent the true incidence because many cases result in pregnancy loss or stillbirth, which are not always captured in standard live-birth registries.
Data regarding the epidemiology of Bilateral Renal Agenesis indicates several distinct patterns:
The primary challenge in tracking Bilateral Renal Agenesis statistics is the high rate of pregnancy termination or spontaneous loss, which often leads to under-reporting in clinical databases. Furthermore, 19 members have joined the DiseaseMaps.org community to share their experiences, providing a crucial real-world perspective on the diagnostic journey and the physical and emotional impact of this rare diagnosis on families.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding clinical concerns.